News article

Funding for SMEs to evaluate medical technologies

27 December 2018


Apply for a share of up to £1.5 million to evaluate innovative medical devices and products

Up to £1.5 million is available to support developers of innovative medicines, medical devices, diagnostics and regulated digital technology to evaluate their product in a real-world clinical setting.

You can choose from two options:

  • planning and preparation for a study - project costs can be up to £50,000
  • a study to collect clinical performance and cost-effectiveness data - project costs can be up to £250,000

The competition, funded by the Office for Life Sciences in partnership with Innovate UK, aims to provide support for small and medium-sized enterprises (SMEs) to generate an evidence base that will enable the evaluation of products that address NHS priorities.

Priority will be given to projects that:

  • reduce cancellations or unnecessary appointments in primary and secondary care
  • reduce the number of people that need to use A&E services
  • improve patient safety and avoid patient harm
  • speed up diagnosis, such as improving the scope of lower cost diagnostic imaging
  • enable earlier diagnosis of cancer
  • support the management of long-term conditions, such as diabetes, chronic pain management, cardiovascular disease, asthma and chronic obstructive pulmonary disease

You can work alone or collaborate with others as unfunded partners or sub-contractors. Only the lead partner can claim grant funding.

The competition closes for applications on midday Wednesday 30 January 2019.

Find out more about this competition and apply.